VivaTech 2025

VivaTech 2025


Hosted By

Brazil

Mirscience Therapeutics

Health
Mirscience Therapeutics develops RNA-based oligonucleotides for age-related diseases. MT-29 targets key genes in sarcopenia via a proprietary platform combining RNA biology and machine learning to unlock non-coding RNA therapeutics
Wed
Thu
Fri
Sat
Healthcare & Wellness
Growth & Investment

More info

Media gallery

URL DE LA  VIDEO DE PRESENTATION

DATES / SEE ALL / MENUS / SESSIONS

GTM